Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study

INSERM CIC 05-02, Centre Hospitalier Universitaire de la Cavale Blanche, Brest, France.
BMJ (online) (Impact Factor: 16.38). 04/2012; 344:e2635. DOI: 10.1136/bmj.e2635
Source: PubMed

ABSTRACT To assess the safety of using single complete compression ultrasonography in pregnant and postpartum women to rule out deep vein thrombosis.
Prospective outcome study.
Two tertiary care centres and 18 private practices specialising in vascular medicine in France and Switzerland.
226 pregnant and postpartum women referred for suspected deep vein thrombosis.
A single proximal and distal compression ultrasonography was performed. All women with a negative complete compression ultrasonography result did not receive anticoagulant therapy and were followed up for a three month period.
Symptoms of venous thromboembolism, second compression ultrasonography or chest imaging, a thromboembolic event, and anticoagulant treatment.
16 women were excluded, mainly because of associated suspected pulmonary embolism. Deep vein thrombosis was diagnosed in 22 out of the 210 included women (10.5%). 10 patients received full dose anticoagulation despite a negative test result during follow-up. Of the 177 patients without deep vein thrombosis and who did not receive full dose anticoagulant therapy, two (1.1%, 95% confidence interval 0.3% to 4.0%) had an objectively confirmed deep vein thrombosis during follow-up.
The rate of venous thromboembolic events after single complete compression ultrasonography in pregnant and postpartum women seems to be within the range of that observed in studies in the non-pregnant population. These data suggest that a negative single complete compression ultrasonography result may safely exclude the diagnosis of deep vein thrombosis in this setting. NCT00740454.


Available from: Marc Righini, Jun 07, 2015
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction The diagnosis of deep vein thrombosis (DVT) in pregnant women remains a challenge for physicians. The ‘LEFt’ clinical decision rule was recently derived, that might help in estimating the pretest probability of DVT during pregnancy. Our aim was to externally validate the LEFt clinical decision rule among pregnant women included in the OPTIMEV study. Materials and Methods The OPTIMEV study is a diagnostic and epidemiologic study that included patients with suspected VTE between November 2004 and January 2006. All patients underwent standardized clinical data collection, and a bilateral whole-leg venous ultrasonography. A 3-month follow-up was performed in all patients with confirmed VTE, and in a randomly selected subsample of patients with negative diagnostic workup. Results Of the 8,256 included patients, 96 were pregnant women. A DVT was diagnosed at CUS in 9 women (9.4%). The LEFtscore was computed in all but 7 women with missing values: one point in case of left (‘L’) leg suspicion, one point for edema (‘E’) and one point if the suspicion occurred during the first trimester (‘Ft’) of pregnancy. Prevalence of confirmed DVT was as follows: 1/30 (3%) in women with no LEFt criteria, 3/35 (9%), 2/20 (10%), and 3/4 (75%) in women with 1, 2 and 3 points, respectively. Conclusions Our results confirm the ability of the LEFt rule to estimate the pretest probability of DVT. Future studies are required to prospectively validate these findings and to define the role of the rule in a diagnostic algorithm for DVT during pregnancy.
    Thrombosis Research 09/2014; 134(3). DOI:10.1016/j.thromres.2014.07.009 · 2.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To test if serum YKL-40 is increased in women developing preeclampsia or small-for-gestational age fetuses. We also assessed the association between uterine artery pulsatility index, notching and serum YKL-40 levels.DesignProspective cohort study.SettingA primary referral unit for obstetric ultrasound.Population1214 unselected pregnant women enrolled at nuchal translucency examination during gestational ages 11+3 to 13+6 weeks.Methods All women had ultrasound and blood sample collection at the nuchal translucency scan, a 20-week malformation scan and 25 and 32 week fetal growth examinations. Uterine artery Doppler was assessed and outcome registered from medical records.Main outcome measuresPreeclampsia, hypertension, small-for-gestational age.ResultsSignificantly higher serum concentrations of YKL-40 were found in women developing preeclampsia compared to the remaining cohort at different gestational age (p<0.0001). Serum YKL-40 was associated with increasing maternal age (p<0.0001), body mass index (p=0.0002), primiparity (p=0.0003) and hypertension (p=0.015). Serum YKL-40 increased from 12 to 20 weeks and decreased from 20-25 and 25-32 weeks. No association was found between preeclampsia and serum YKL-40. Small-for-gestational-age at birth was significantly associated with a 5.4% increase in serum YKL-40 at gestational age 32 weeks (95% CI: 1.5-9.3, p=0.005). An association was found between uterine artery pulsatility index at 32 weeks and small-for-gestational age (p=0.0015) but not between YKL-40 and uterine artery notching (p=0.83).Conclusions Serum YKL-40 was not associated with preeclampsia. Increasing serum YKL-40 was related to maternal age, body mass index and small-for-gestational age and may reflect an exaggerated inflammatory response.This article is protected by copyright. All rights reserved.
    Acta Obstetricia Et Gynecologica Scandinavica 05/2014; 93(8). DOI:10.1111/aogs.12432 · 1.99 Impact Factor